Picture of Celularity logo

CELU — Celularity News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Celularity Inc reports results for the quarter ended in September - Earnings Summary

* Celularity Inc  CELU.OQ  reported quarterly adjusted
earnings of
3 cents​​ per share for the quarter ended in September. The mean
expectation of six analysts for the quarter was for a loss of 26
cents per share.
    * Revenue fell 61.1% to $4.14 million from a year ago;
analysts
expected $5.74 million. 
    * Celularity Inc's reported EPS for the quarter was 3
cents​.
    * The mean earnings estimate of analysts had fallen by
about 0.6%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Celularity Inc shares had fallen by 12.1% this quarter and
lost 60.4% so far this year.
    * The company reported quarterly net income of $4.8 million.
    * Wall Street's median 12-month price target for Celularity
Inc is
$10.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 10:02 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.26          0.03           Beat
 Jun. 30 2022      -0.26          0.32           Beat
 Mar. 31 2022      -0.26          -0.48          Missed
 Dec. 31 2021      -0.31          -0.03          Beat

Recent news on Celularity

See all news